What is it about?
This is a series of cases to do root cause analysis of patients presenting with diabetic ketoacidosis while being prescribed sodium glucose co transporter 2 inhibitors for type 2 diabetes.
Featured Image
Why is it important?
SGLT2 inhibitor is an important class of drugs for type 2 diabetes to help prevent cardiovascular morality
Perspectives
This drug will be increasingly prescribed in future and may become drug of choice for use in type 2 diabetes by the cardiologists. It is important to explore any potential side effects in detail.
Jawad Bashir
Swansea University
Read the Original
This page is a summary of: A case series of DKA occurring in patients receiving treatment with SGLT-2 inhibitors, Diabetes Obesity and Metabolism, March 2018, Wiley,
DOI: 10.1111/dom.13271.
You can read the full text:
Contributors
The following have contributed to this page
